230 related articles for article (PubMed ID: 37343647)
21. Understanding the mode-of-action of Cassia auriculata via in silico and in vivo studies towards validating it as a long term therapy for type II diabetes.
Mohd Fauzi F; John CM; Karunanidhi A; Mussa HY; Ramasamy R; Adam A; Bender A
J Ethnopharmacol; 2017 Feb; 197():61-72. PubMed ID: 27452659
[TBL] [Abstract][Full Text] [Related]
22. Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression.
Ko JC; Zheng HY; Chen WC; Peng YS; Wu CH; Wei CL; Chen JC; Lin YW
Biochem Pharmacol; 2016 Dec; 122():90-98. PubMed ID: 27666600
[TBL] [Abstract][Full Text] [Related]
23. Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.
Corno C; Gatti L; Arrighetti N; Carenini N; Zaffaroni N; Lanzi C; Perego P
Biochem Pharmacol; 2017 Jul; 136():40-50. PubMed ID: 28404378
[TBL] [Abstract][Full Text] [Related]
24. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
25. Targeting PI3K/AKT signaling pathway in obesity.
Savova MS; Mihaylova LV; Tews D; Wabitsch M; Georgiev MI
Biomed Pharmacother; 2023 Mar; 159():114244. PubMed ID: 36638594
[TBL] [Abstract][Full Text] [Related]
26. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery.
Chwalek K; Bray LJ; Werner C
Adv Drug Deliv Rev; 2014 Dec; 79-80():30-9. PubMed ID: 24819220
[TBL] [Abstract][Full Text] [Related]
27. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.
Li J; Ma J; Tian Y; Zhao P; Liu X; Dong H; Zheng W; Feng S; Zhang L; Wu M; Zhu L; Liu S; Zhao D
J Ethnopharmacol; 2020 Jul; 257():112796. PubMed ID: 32344236
[TBL] [Abstract][Full Text] [Related]
28. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy.
Xi S; Peng Y; Minuk GY; Shi M; Fu B; Yang J; Li Q; Gong Y; Yue L; Li L; Guo J; Peng Y; Wang Y
J Ethnopharmacol; 2016 Aug; 190():1-12. PubMed ID: 27235019
[TBL] [Abstract][Full Text] [Related]
29. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.
Abdel-Wahab AF; Mahmoud W; Al-Harizy RM
Pharmacol Res; 2019 Dec; 150():104511. PubMed ID: 31678210
[TBL] [Abstract][Full Text] [Related]
30. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
[TBL] [Abstract][Full Text] [Related]
31. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway.
Xiao M; Men LN; Xu MG; Wang GB; Lv HT; Liu C
Eur J Pharmacol; 2014 Nov; 743():11-6. PubMed ID: 25257463
[TBL] [Abstract][Full Text] [Related]
32. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
33. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
[TBL] [Abstract][Full Text] [Related]
34. Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling.
Grunt TW; Mariani GL
Curr Cancer Drug Targets; 2013 Feb; 13(2):188-204. PubMed ID: 23215720
[TBL] [Abstract][Full Text] [Related]
35. Denatured protein-coated docetaxel nanoparticles: Alterable drug state and cytosolic delivery.
Zhang L; Xiao Q; Wang Y; Zhang C; He W; Yin L
Int J Pharm; 2017 May; 523(1):1-14. PubMed ID: 28323094
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronic acid thiol modified injectable hydrogel: Synthesis, characterization, drug release, cellular drug uptake and anticancer activity.
Xu K; Yao H; Fan D; Zhou L; Wei S
Carbohydr Polym; 2021 Feb; 254():117286. PubMed ID: 33357859
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor effects of osthole on ovarian cancer cells in vitro.
Jiang G; Liu J; Ren B; Tang Y; Owusu L; Li M; Zhang J; Liu L; Li W
J Ethnopharmacol; 2016 Dec; 193():368-376. PubMed ID: 27566206
[TBL] [Abstract][Full Text] [Related]
38. Role of cardioprotective agents on chemotherapy-induced heart failure: A systematic review and network meta-analysis of randomized controlled trials.
Li X; Li Y; Zhang T; Xiong X; Liu N; Pang B; Ruan Y; Gao Y; Shang H; Xing Y
Pharmacol Res; 2020 Jan; 151():104577. PubMed ID: 31790821
[TBL] [Abstract][Full Text] [Related]
39. Should we keep rocking? Portraits from targeting Rho kinases in cancer.
de Sousa GR; Vieira GM; das Chagas PF; Pezuk JA; Brassesco MS
Pharmacol Res; 2020 Oct; 160():105093. PubMed ID: 32726671
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
